| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 03/26/2009 | WO2009036996A2 Small molecule bradykinin b1 receptor antagonists |
| 03/26/2009 | WO2009036766A1 Cyanoisoquinoline |
| 03/26/2009 | WO2009016564A3 2-aza-bicyclo[3.3.0]octane derivatives |
| 03/26/2009 | WO2009006389A8 Pyrimidine derivatives useful as raf kinase inhibitors |
| 03/26/2009 | WO2008141731A3 Inhibitors of hypoxia inducible factor (hif) useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 03/26/2009 | WO2008139288A3 Substituted heterocyclic derivatives and compositions and their pharmaceutical use as antibacterials |
| 03/26/2009 | WO2008104134A3 A method for the preparation of zolmitriptan |
| 03/26/2009 | US20090082567 2,4-pyrimidinediamine compounds and their uses |
| 03/26/2009 | US20090082403 Pyridine derivatives substituted by heterocyclic ring and phosphonoamino group, and anti-fungal agent containing same |
| 03/26/2009 | US20090082390 Piperidine compounds for use as orexin receptor antagonist |
| 03/26/2009 | US20090082351 Pesticide pyrimidinyloxy substituted phenylamidine derivatives |
| 03/26/2009 | US20090082350 Soluble epoxide hydrolase inhibitors |
| 03/26/2009 | US20090082345 Benzothiazole- and benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitors |
| 03/26/2009 | US20090082330 Certain substituted amides, method of making, and method of use thereof |
| 03/26/2009 | US20090082329 Novel Sulphur-Containing Cyclic Urea Derivatives, Preparation Thereof and Pharmaceutical Use Thereof as Kinase Inhibitors |
| 03/26/2009 | US20090082308 histone deacetylase inhibitors; antiproliferative; antineoplastic; thioredoxin (TRX)-mediated diseases such as autoimmune, allergy, inflammatory diseases; and neurodegenerative diseases; hydroxamic acid moiety; 6-Carbamoylmethyl-benzo[b]thiophene-2-carboxylic acid (4-amino-1-phenyl-1H-pyrazol-3-yl)amide |
| 03/26/2009 | US20090081757 Adsorbents Comprising Anthraquinone Dye-Ligends for the Separation of Biological Materials |
| 03/26/2009 | US20090081165 Bicyclic heteroaryl derivatives |
| 03/26/2009 | US20090079343 Organic electroluminescent device |
| 03/26/2009 | CA2700051A1 Small molecule bradykinin b1 receptor antagonists |
| 03/26/2009 | CA2699989A1 N-phenyl-dioxo-hydro pyrimidines useful as hepatitis c virus (hcv) inhibitor |
| 03/26/2009 | CA2699986A1 Anti-infective pyrimidines and uses thereof |
| 03/26/2009 | CA2699981A1 Uracil or thymine derivative for treating hepatitis c |
| 03/26/2009 | CA2699707A1 Inhibitors of the interaction between mdm2 and p53 |
| 03/26/2009 | CA2697551A1 Piperidine derivatives as modulators of gpr119 activity |
| 03/26/2009 | CA2696508A1 Diacylglycerol acyltransferase inhibitors |
| 03/26/2009 | CA2691474A1 Cyanoisoquinoline |
| 03/26/2009 | CA2691031A1 N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl)arylsulfonamides |
| 03/25/2009 | EP2039694A1 CGRP receptor antagonists |
| 03/25/2009 | EP2039685A2 Heterobicyclic compounds as P38 inhibitors |
| 03/25/2009 | EP2038278A2 Thiazoline and oxazoline derivatives and their methods of use |
| 03/25/2009 | EP2038277A2 Xinafoate salt of a substituted 5-oxazol-2-yl-quinoline compound |
| 03/25/2009 | EP2038276A1 Azolylmethyloxiranes, their use for controlling phytopathogenic fungi and compositions comprising them |
| 03/25/2009 | EP2038274A2 Transcription factor modulating compounds and methods of use thereof |
| 03/25/2009 | EP2038272A2 Pyridinonyl pdk1 inhibitors |
| 03/25/2009 | EP2038265A2 Human protein tyrosine phosphatase inhibitors and methods of use |
| 03/25/2009 | EP2038264A1 Tetrazole-substituted arylamides |
| 03/25/2009 | EP2038261A2 Pyrazine derivatives with extended conjugation and uses thereof |
| 03/25/2009 | EP2038254A2 Bicyclic compositions and methods for modulating a kinase cascade |
| 03/25/2009 | EP2037891A1 Tablets comprising candesartan cilexetil |
| 03/25/2009 | EP1756063A4 Amido compounds and their use as pharmaceuticals |
| 03/25/2009 | CN100471858C Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
| 03/25/2009 | CN100471854C Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| 03/25/2009 | CN100471853C Phenyl-thiophene type vitamin D receptor modulators |
| 03/25/2009 | CN100471842C Quinolone derivative or its salt |
| 03/25/2009 | CN100471838C VLA-4 inhibitors |
| 03/24/2009 | US7507834 Cyclin dependent kinases (CDK2) inhibitors; 4-[5-(3-bromo-phenyl)-2H-pyrazol-3-ylamino]-benzenesulfonamide; cancer and hyperproliferative diseases, such as psoriasis |
| 03/24/2009 | US7507757 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 03/24/2009 | US7507755 Inhibitors of cathepsin s |
| 03/24/2009 | US7507734 Pyridazinone derivatives |
| 03/24/2009 | US7507733 11b-HSD1 inhibitors for the treatment of diabetes |
| 03/24/2009 | US7507732 6,7-Dihydro-5H-cyclopenta[b]pyridine and 5,6,7,8-tetrahydroquinoline compounds; 5-HT2c receptor agonists; to treat diseases like obesity, depression, atypical depression, anxiety, epilepsy, lower urinary tract dysfunction; less toxic; selectivity |
| 03/24/2009 | US7507730 Substituted pyrazolo[1,5-a]pyrimidines as potassium channel activators |
| 03/24/2009 | CA2437501C Process for the manufacture of phenylacetic acid derivatives |
| 03/24/2009 | CA2422380C Pyrazole compounds useful as protein kinase inhibitors |
| 03/24/2009 | CA2224060C Manganese or iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
| 03/19/2009 | WO2009035162A1 6-pyrimidinyl-pyrimid-2-one derivative |
| 03/19/2009 | WO2009035159A1 3-methyl-2- ( (2s) -2- (4- (3-methyl-1, 2, 4-oxadiazol-5-yl) phenyl) morpholino) -6- (pyrimidin-4-yl) pyrimidin-4 (3h) -one as tau protein kinase inhibitor |
| 03/19/2009 | WO2009035067A1 Glucocorticoid receptor agonists consisting of 1,3,3-tri- methyl-7-phenyl-3,4-dihydro-1h-quinoxalin-2-one derivatives |
| 03/19/2009 | WO2009035004A1 Substituted isoxazoline compound and pest control agent |
| 03/19/2009 | WO2009034396A2 Method and means relating to multiple herbicide resistance in plants |
| 03/19/2009 | WO2009034388A1 Compounds for the treatment of metabolic disorders |
| 03/19/2009 | WO2009034043A1 Novel phenoxazin-3-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 03/19/2009 | WO2009034042A1 Novel benzooxazol- and benzooxathiol-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 03/19/2009 | WO2009034029A2 1-substituted 4-heterocyclylpiperidines for use as cgrp antagonists |
| 03/19/2009 | WO2009034028A2 Novel compounds |
| 03/19/2009 | WO2009033360A1 Benzamide derivatives, their preparation and uses in medicine thereof |
| 03/19/2009 | WO2009014637A3 Heterocyclic amide compounds as protein kinase inhibitors |
| 03/19/2009 | WO2008155069A3 Substituted oxazolidinones and use thereof |
| 03/19/2009 | WO2008154528A3 Isoxazoline insecticides |
| 03/19/2009 | US20090076275 Diacylglycerol acyltransferase inhibitors |
| 03/19/2009 | US20090076274 Benzoxazinone derivatives, preparation thereof and uses in the treatment of cns and other disorders |
| 03/19/2009 | US20090076264 Deuterium-enriched rivaroxaban |
| 03/19/2009 | US20090076103 Stem cell differentiating agents and uses therefor |
| 03/19/2009 | US20090076088 Thrombin Receptor Antagonists |
| 03/19/2009 | US20090076070 Hetero compound |
| 03/19/2009 | US20090076036 Deuterium-enriched risperidone |
| 03/19/2009 | US20090076008 Deuterium-enriched fosaprepitant |
| 03/19/2009 | US20090076007 Deuterium-enriched aprepitant |
| 03/19/2009 | US20090076006 Hsp90 inhibitors containing a zinc binding moiety |
| 03/19/2009 | US20090076004 1-Aryl-or heteroaryl-3-aryl-or heteroarylindole-2-carboxylic acids or esters: e.g., 5-(4-tert-Butylphenyl)-1,3-bis(4-isopropoxyphenyl)-indole-2-carboxylic acid; inhibition of the activity of microsomal prostaglandin E synthase-1, leukotriene C4 and/or 5-lipoxygenase-activating protein; analgesics |
| 03/19/2009 | US20090076003 Phthalazine Derivatives with Angiogenesis Inhibiting Activity |
| 03/19/2009 | US20090076000 Deuterium-enriched mycophenolate mofetil |
| 03/19/2009 | US20090075997 Deuterium-enriched satavaptan |
| 03/19/2009 | US20090075996 Heterotetracyclic compounds as tpo mimetics |
| 03/19/2009 | US20090075993 N-[3-(1 -piperidinyl)propoxy]-pyridin-1-oxide-3-carboxamidine ; increasing vaso-relaxation of a vessel associated with endothelial cells |
| 03/19/2009 | US20090075988 phosphodiesterase inhibitors such as 1-[3-(4-fluoro-phenyl-piperazin-1-yl]-6,7-dimethoxy-isoquinoline-4-carbonitrile, having improved solubility, metabolic stability and/or bioavailability, used for the treatment of neurodegenerative diseases, psychological disorders and drug addiction |
| 03/19/2009 | US20090075986 Anti-inflammatory medicaments |
| 03/19/2009 | US20090075985 Aryl sulfonamide peri-substituted bicyclics for occlusive artery disease |
| 03/19/2009 | US20090075981 INHIBITORS OF p38 |
| 03/19/2009 | US20090075980 Pyrazolopyridines and Analogs Thereof |
| 03/19/2009 | US20090075979 CETP Inhibitors |
| 03/19/2009 | US20090075968 CETP inhibitors |
| 03/19/2009 | US20090075939 Novel HIV reverse transcriptase inhibitors |
| 03/19/2009 | US20090075938 Treatment of duchenne muscular dystrophy |
| 03/19/2009 | US20090075148 Benzoxazine-based monomer, polymer thereof, electrode for fuel cell including the same, electrolyte membrane for fuel cell including the same, and fuel cell using the same |
| 03/19/2009 | CA2737047A1 Method and means relating to multiple herbicide resistance in plants |
| 03/19/2009 | CA2698819A1 6-pyrimidinyl-pyrimid-2-one derivative |
| 03/19/2009 | CA2698818A1 3-methyl-2- ( (2s) -2- (4- (3-methyl-1, 2, 4-oxadiazol-5-yl) phenyl) morpholino) -6- (pyrimidin-4-yl) pyrimidin-4 (3h) -one as tau protein kinase inhibitor |
| 03/18/2009 | EP2036905A1 Pyridylisoxazole derivative |